Compare DexCom, Inc. (DXCM) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Alliant Energy Corporation — how do they compare? DexCom, Inc. trades at $77.79 (market cap $28.06B), while Alliant Energy Corporation trades at $74.63 (market cap $19.25B). The key difference: DexCom, Inc. is the larger of the two by market cap, and Alliant Energy Corporation pays a 2.8% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | LNT | |
|---|---|---|
Market Cap | $28.06B | $19.25B |
Sector | Health | Utilities |
52-Week High | $89.53 | $78.03 |
52-Week Low | $54.84 | $62.87 |
Enterprise Value | $27.03B | $30.98B |
Dividend Yield | — | 2.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Alliant Energy (LNT) trades at $75.34, down 1.27% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with 18.58% net income margin and consistent earnings beats in recent quarters. Analyst consensus is positive with a $78.50 price target and 52% buy ratings. The company's $13.4B clean energy investment plan supports long-term growth amid rising data center demand.
LNT offers steady utility growth with dividend income, though increasing debt levels and regulatory risks require monitoring. The stock presents a balanced opportunity for income and capital appreciation investors, with technical support at $74 providing near-term stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
